Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × carfilzomib × Plasma cell × Clear all

Phase

Status

Completed 56 Active not recruiting 40 Recruiting 22 Terminated 20 Unknown 7 Withdrawn 6 Not yet recruiting 6 No longer available 1 Enrolling by invitation 1 Approved for marketing 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoldering Multiple Myeloma 1 Multiple Myeloma 1

Interventions

Lenalidomide 2 Dexamethasone 2 carfilzomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03815279 2019-08-16

iStopMM

Landspitali University Hospital

Phase 2 Enrolling by invitation

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡